The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Geary Richard S since 2015.
This trader's CIK number is 1442730.
At the time of last reporting, Geary Richard S was the EVP, Chief Development Officer of Ionis Pharmaceuticals Inc. (stock ticker symbol IONS).
Also see all insider trading activities at Ionis Pharmaceuticals Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | IONS | 0 | $0 | 28,478 | $1,210,228 | 18,901 | $0 |
2024 | IONS | 0 | $0 | 12,380 | $616,891 | 19,852 | $0 |
2023 | IONS | 0 | $0 | 31,018 | $1,442,383 | 43,208 | $1,004,791 |
2022 | IONS | 0 | $0 | 0 | $0 | 21,391 | $0 |
2021 | IONS | 0 | $0 | 141 | $8,389 | 17,598 | $0 |
2020 | IONS | 0 | $0 | 25,000 | $1,253,748 | 38,139 | $996,749 |
2019 | IONS | 0 | $0 | 62,239 | $4,919,754 | 69,325 | $1,790,984 |
2018 | IONS | 0 | $0 | 2,723 | $140,942 | 6,732 | $0 |
2017 | IONS | 0 | $0 | 10,709 | $609,076 | 13,707 | $65,432 |
2016 | IONS | 0 | $0 | 2,162 | $89,634 | 5,427 | $0 |
2015 | IONS | 0 | $0 | 28,235 | $2,039,274 | 27,129 | $262,333 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-09-02 | IONS | Sale | 10,000 | 50.37 | 503,670 |
2025-08-05 | IONS | Sale | 10,000 | 42.86 | 428,590 |
2025-01-31 | IONS | Sale | 1,406 | 32.41 | 45,561 |
2025-01-15 | IONS | Option Ex | 18,901 | .00 | 0 |
2025-01-16 | IONS | Sale | 7,072 | 32.86 | 232,407 |
2024-08-29 | IONS | Sale | 331 | 49.63 | 16,427 |
2024-08-28 | IONS | Sale | 320 | 49.16 | 15,731 |
2024-08-05 | IONS | Sale | 2,430 | 48.00 | 116,640 |
2024-02-02 | IONS | Sale | 1,961 | 50.04 | 98,134 |
2024-01-17 | IONS | Sale | 7,338 | 50.42 | 369,959 |
2024-01-16 | IONS | Option Ex | 19,852 | .00 | 0 |
2023-12-21 | IONS | Sale | 4,112 | 49.29 | 202,680 |
2023-12-21 | IONS | Option Ex | 4,112 | 47.34 | 194,662 |
2023-12-20 | IONS | Sale | 6,500 | 49.64 | 322,640 |
2023-12-20 | IONS | Option Ex | 6,500 | 47.34 | 307,710 |
2023-12-14 | IONS | Sale | 10,613 | 49.70 | 527,466 |
2023-12-14 | IONS | Option Ex | 10,613 | 47.34 | 502,419 |
2023-02-06 | IONS | Sale | 1,920 | 40.66 | 78,071 |
2023-01-17 | IONS | Option Ex | 21,983 | .00 | 0 |
2023-01-18 | IONS | Sale | 7,873 | 39.57 | 311,526 |
2022-01-18 | IONS | Option Ex | 21,391 | .00 | 0 |
2021-01-15 | IONS | Option Ex | 17,598 | .00 | 0 |
2021-01-13 | IONS | Sale | 141 | 59.50 | 8,389 |
2020-11-25 | IONS | Option Ex | 11,920 | 39.87 | 475,250 |
2020-11-25 | IONS | Sale | 11,920 | 50.05 | 596,596 |
2020-11-23 | IONS | Option Ex | 10,700 | 39.87 | 426,609 |
2020-11-24 | IONS | Option Ex | 2,380 | 39.87 | 94,890 |
2020-11-23 | IONS | Sale | 10,700 | 50.11 | 536,177 |
2020-11-24 | IONS | Sale | 2,380 | 50.83 | 120,975 |
2020-01-15 | IONS | Option Ex | 13,139 | .00 | 0 |
2019-12-04 | IONS | Option Ex | 10,000 | 14.69 | 146,900 |
2019-12-04 | IONS | Sale | 10,000 | 65.00 | 650,000 |
2019-12-02 | IONS | Option Ex | 5,000 | 14.69 | 73,450 |
2019-12-02 | IONS | Sale | 5,000 | 65.06 | 325,285 |
2019-04-08 | IONS | Option Ex | 46,240 | 33.97 | 1,570,634 |
2019-04-08 | IONS | Sale | 46,240 | 84.01 | 3,884,529 |
2019-02-13 | IONS | Sale | 999 | 60.00 | 59,940 |
2019-01-15 | IONS | Option Ex | 8,085 | .00 | 0 |
2018-01-16 | IONS | Sale | 2,723 | 51.76 | 140,942 |
2018-01-15 | IONS | Option Ex | 6,732 | .00 | 0 |
2017-10-13 | IONS | Sale | 8,268 | 60.00 | 496,080 |
2017-10-13 | IONS | Option Ex | 7,461 | 8.77 | 65,432 |
2017-01-15 | IONS | Option Ex | 6,246 | .00 | 0 |
2017-01-17 | IONS | Sale | 2,441 | 46.29 | 112,996 |
2016-01-15 | IONS | Option Ex | 5,427 | .00 | 0 |
2016-01-19 | IONS | Sale | 2,162 | 41.46 | 89,634 |
2015-03-19 | ISIS | Sale | 8,000 | 75.00 | 600,032 |
2015-03-19 | ISIS | Option Ex | 8,000 | 14.69 | 117,520 |
2015-03-05 | ISIS | Option Ex | 15,080 | 9.60 | 144,813 |
2015-03-05 | ISIS | Sale | 18,095 | 71.33 | 1,290,734 |
2015-01-15 | ISIS | Option Ex | 4,049 | .00 | 0 |
2015-01-16 | ISIS | Sale | 1,543 | 67.96 | 104,868 |
2015-01-12 | ISIS | Sale | 597 | 73.10 | 43,640 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Geary Richard S (EVP, Chief Development Officer of Ionis Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.